Condition: Allergic Diseases · Chronic Spontaneous Urticaria (CSU) · Sponsor: Yuhan Corporation
This study aims to evaluate the efficacy and safety of lesigercept in approximately 150 participants with CSU. By enrolling participants with an inadequate response to H1-antihistamines, including those previously treated with omalizumab, this study is expected to provide evidence for the clinical utility of lesigercept and to further characterize its benefit-risk profile in the target participant population.
This description comes directly from the study's public registry record.
JinHyun Choi · +82-2-828-0850 · clinicaltrials@yuhan.co.kr
JeungJin Yoon · +82-2-828-0396 · clinicaltrials@yuhan.co.kr
Always discuss trial participation with your own doctor first.
| Diagnostic & Consultative Centre Ascendent EOOD | Sofia, Sofia, Bulgaria | Not Yet Recruiting |
| UMHAT "Aleksandrovska" | Sofia, Sofia, Bulgaria | Not Yet Recruiting |
| Medical Center Hera EOOD | Sofia, Sofia, Bulgaria | Not Yet Recruiting |
| UMHATEM "N. I. Pirogov" | Sofia, Sofia, Bulgaria | Not Yet Recruiting |
| Dermatology Hospital of Southern Medical University (Guangdong Province Dermatology Hospital) | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The University of Hong Kong-Shenzhen Hospital | Shenzhen, Guangdong, China | Not Yet Recruiting |
| Alergologia Plus Sp. z o. o. | Poznan, Greater Poland Voivodeship, Poland | Not Yet Recruiting |
| Centrum Medyczne ALL-MED | Krakow, Lesser Poland Voivodeship, Poland | Not Yet Recruiting |
| Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o. | Krakow, Lesser Poland Voivodeship, Poland | Not Yet Recruiting |
| Alergo-Med Ośrodek Badań Klinicznych Sp. z o.o. | Tarnów, Lesser Poland Voivodeship, Poland | Not Yet Recruiting |
| ALL-MED Specjalistyczna Opieka Medyczna | Wroclaw, Lower Silesian Voivodeship, Poland | Not Yet Recruiting |
| DERMACEUM sp. z o.o., DERMACEUM Centrum Medyczne | Wroclaw, Lower Silesian Voivodeship, Poland | Not Yet Recruiting |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07415551